- Home
- BCLI vs VRME Comparison
BCLI vs VRME Comparison
Compare BCLI & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- VRME
- Stock Information
- Founded
- BCLI 2000
- VRME 1999
- Country
- BCLI United States
- VRME United States
- Employees
- BCLI N/A
- VRME N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- VRME EDP Services
- Sector
- BCLI Health Care
- VRME Technology
- Exchange
- BCLI Nasdaq
- VRME Nasdaq
- Market Cap
- BCLI 7.9M
- VRME 9.4M
- IPO Year
- BCLI N/A
- VRME N/A
- Fundamental
- Price
- BCLI $1.16
- VRME $0.70
- Analyst Decision
- BCLI Strong Buy
- VRME Strong Buy
- Analyst Count
- BCLI 1
- VRME 2
- Target Price
- BCLI $30.00
- VRME $1.38
- AVG Volume (30 Days)
- BCLI 141.4K
- VRME 75.7K
- Earning Date
- BCLI 05-15-2025
- VRME 05-13-2025
- Dividend Yield
- BCLI N/A
- VRME N/A
- EPS Growth
- BCLI N/A
- VRME N/A
- EPS
- BCLI N/A
- VRME N/A
- Revenue
- BCLI N/A
- VRME $22,903,000.00
- Revenue This Year
- BCLI N/A
- VRME N/A
- Revenue Next Year
- BCLI N/A
- VRME $5.35
- P/E Ratio
- BCLI N/A
- VRME N/A
- Revenue Growth
- BCLI N/A
- VRME N/A
- 52 Week Low
- BCLI $0.72
- VRME $0.55
- 52 Week High
- BCLI $10.05
- VRME $5.00
- Technical
- Relative Strength Index (RSI)
- BCLI 50.13
- VRME 47.55
- Support Level
- BCLI $1.12
- VRME $0.65
- Resistance Level
- BCLI $1.26
- VRME $0.83
- Average True Range (ATR)
- BCLI 0.14
- VRME 0.05
- MACD
- BCLI 0.02
- VRME 0.00
- Stochastic Oscillator
- BCLI 42.86
- VRME 28.92
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.